Nabi Biopharma’s latest biotech-stock casualty
July 27, 2011 at 13:33 PM EDT
Analysts don’t expect shares of the company, which has had much riding on a smoking-cessation product in development, to rebound any time soon.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.